Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Orally available antiproliferative imidazoles under study at Abbott for use in cancer

March 21, 2001

Lorus receives FDA approval to evaluate antisense compound in phase I

March 21, 2001

Banyu presents new series of biarylurea CDK inhibitors as antineoplastic agents

March 20, 2001

Merck describes synthesis and use of new inhibitors of Ras prenylation

March 20, 2001

Heptapeptide LHRH antagonists in the Abbott pipeline

March 19, 2001

Antisense oligonucleotides designed at Isis to modulate Akt-3

March 19, 2001

Abbott and NaPro BioTherapeutics file ANDA for paclitaxel

March 19, 2001

Liposomal FGF-2 vaccine shows antiangiogenic efficacy

March 19, 2001

Somatostatin receptor modulators designed at SCRAS

March 16, 2001

Bioenvision announces codevelopment partner for clofarabine

March 16, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...